Archive for 2011

Special Promotion From DrugPatentWatch

I am running a special discount at DrugPatentWatch through the end of November: 50% off the Global and Individual Country Drug Patent Inventor Reports through November 30th 2011. These Pharmaceutical Industry Reports are produced by data-mining the DrugPatentWatch Database, and provide detailed information on FDA-approved pharmaceutical drugs. Please contact us with any special data needs […]

2012 Venture Pitch Competition Call for Entrants

The Association of University Technology Managers (AUTM) 2012 Venture Pitch Competition is calling for finalists to present to a venture capital judging panel at the AUTM Annual Meeting (which will be held in Anaheim from March 14-17, 2012). The competition is open to all disciplines this year. So whether your company is considered life science, […]

Drug Patent Expirations in November 2011

Drug Patent Expirations in November 2011 *Drugs may be covered by multiple patents Tradename Applicant Generic Name Patent Number Patent Expiration APHTHASOL Uluru amlexanox 5,362,737 Nov 8, 2011 MAGNEVIST Bayer Hlthcare gadopentetate dimeglumine 5,362,475 Nov 8, 2011 ABLAVAR Lantheus Medcl gadofosveset trisodium 5,362,475 Nov 8, 2011 OMNISCAN Ge Healthcare gadodiamide 5,362,475 Nov 8, 2011 SYMBICORT […]

FDA at BIO 2011 – Weighing a hefty mission: Where is the balance?

The mission of the Food and Drug Administration (FDA) is to promote public health by ensuring the safety and quality of food and medical products sold in the United States. At this year’s annual Biotechnology Industry Organization (BIO) convention, sig…

Patent strategies for life sciences companies to navigate the changing patent landscape

As a result of the global recession that began in 2008, life sciences companies face a groundswell of new business and regulatory pressures that includes health care and patent reform, increased pricing pressures, and diluted markets. Bringing new prod…